Get started
Author

Joachim Deeg

Observed names: Deeg, Joachim, Joachim H Deeg, Joachim H. Deeg
OpenAlex ID: A5103578690
Cord-Blood Transplantation in Patients with Minimal Residual Disease
2016 · Filippo Milano, Ted Gooley, et al. · New England Journal of Medicine · 445
PDF
Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical Siblings
1983 · Rainer Storb, Ross L. Prentice, et al. · New England Journal of Medicine · 431
A role for tumour necrosis factor‐α, Fas and Fas‐Ligand in marrow failure associated with myelodysplastic syndrome
1998 · Geoffrey M. Gersuk, Cassandra Beckham, et al. · British Journal of Haematology · 234
Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome
2019 · Ehab Atallah, Brent Logan, et al. · JAMA Oncology · 61
PDF
Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation
2004 · Paul J. Martin, Ji Pei, et al. · Transplantation and Cellular Therapy · 58
PDF
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease
2000 · Fabrizio Carnevale-Schianca, Paul Martin, et al. · Transplantation and Cellular Therapy · 55
PDF
Acute graft versus host disease after orthotopic liver transplantation
2012 · Inga Mandac Rogulj, Joachim Deeg, et al. · Journal of Hematology & Oncology · 39
PDF
Core‐binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I‐ CBF it)
2018 · Celalettin Ustun, Elizabeth Morgan, et al. · Cancer Medicine · 26
PDF
Medical and Psychosocial Issues in Transplant Survivors
2007 · Karen L. Syrjala, Paul Martin, et al. · Springer eBooks · 25
Lymphocytic Bronchitis Unrelated to Acute Graftversus-host Disease in Canine Marrow Graft Recipients
1984 · Kevin D. OʼBrien, Robert C. Hackman, et al. · Transplantation · 22
The Third Consensus Conference on the treatment of aplastic anemia
2011 · Seiji Kojima, Shinji Nakao, et al. · International Journal of Hematology · 18
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study
2023 · Gregory A. Abel, Donnie Hebert, et al. · Blood Advances · 17
Outcome of Patients 65 Years and Older with Myelodysplastic Syndrome (MDS) Receiving Allogeneic Hematopoietic Stem Cell Transplantation Compared to Patients 55-64 Years of Age
2015 · Ehab Atallah, Mary M. Horowitz, et al. · Blood · 13
Are Hypomethylating Agents Replacing Induction-Type Chemotherapy before Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome?
2014 · Ibrahim Yakoub-Agha, Joachim Deeg · Transplantation and Cellular Therapy · 13
Prolonged Survival in Bi-Allelic TP53-Mutated (TP53mut) MDS Subjects Treated with Oral Decitabine/Cedazuridine in the Ascertain Trial (ASTX727-02)
2022 · Michael R. Savona, James K McCloskey, et al. · Blood · 12
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions
2023 · Amy E. DeZern, Johannes B. Goll, et al. · Blood Advances · 9
PDF
The Characteristics and Prognosis of Patients with Clonal Cytopenias of Undetermined Significance, Including Cancer and Therapy-Related Clonal Cytopenias
2022 · Zhuoer Xie, Alexandra Smith, et al. · Blood · 6
Medical and Psychosocial Issues in Transplant Survivors
2007 · Karen L. Syrjala, Paul Martin, et al. · Springer eBooks · 5
Hematopoietic Cell Transplantation for Older Patients With Mds
2014 · Mazyar Shadman, Joachim Deeg · Mediterranean Journal of Hematology and Infectious Diseases · 3
PDF
Therapeutic Targeting of Spliceosome Mutant Myeloid Neoplasms Via PARP1 Inhibition
2022 · Sayantani Sinha, Zhiyan Silvia Liu, et al. · Blood · 2
[Expression of epidermal growth factor receptor and its relationship to apoptosis in myelodysplastic syndromes].
2003 · Xiao Li, Quan Pu, et al. · PubMed · 2
MPN-183: Preliminary Gastrointestinal Safety and Tolerability of Fedratinib from the Phase IIIb FREEDOM Trial in Patients with Intermediate- or High-Risk Myelofibrosis Previously Treated with Ruxolitinib
2020 · Vikas Gupta, Abdulraheem Yacoub, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Post-Hematopoietic Stem Cell Transplantation Minimal Residual Disease and Early Relapses in MDS and AML Evolving from MDS
2015 · Moreno Festuccia, Kelsey Baker, et al. · Blood · 1
[Biological behavior of stromal cell-derived factor-1 on migration, adhesion and apoptosis in different kinds of AML cell lines].
2008 · Chun-Kang Chang, Xiao Li, et al. · PubMed · 1
Exposure to agent orange and risk of myelodysplastic syndromes
2025 · Mikkael Sekeres, Amy DeZern, et al. · Blood
PDF
Works count: 31
Citation count: 1,499
H-index: 13
I10-index: 15
Year
Topic
Type